McLachlan, C. S. (2020). The angiotensin-converting enzyme 2 (ACE2) receptor in the prevention and treatment of COVID-19 are distinctly different paradigms. Clinical Hypertension, 26(1), 1-3. https://clinicalhypertension.biomedcentral.com/articles/10.1186/s40885-020-00147-x